Cargando…
聚乙二醇脂质体阿霉素在CHOP方案治疗侵袭性非霍奇金淋巴瘤中的Ⅰ期剂量递增试验的安全性探索
OBJECTIVE: To explore the maximum tolerated dose of pegylated liposomal doxorubicin (PLD) in combination with cyclophosphamide, vincristine and prednisone as a modified CHOP regimen for aggressive non-Hodgkin lymphoma. METHODS: Patients with newly diagnosed aggressive non-Hodgkin lymphoma were eligi...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348486/ https://www.ncbi.nlm.nih.gov/pubmed/28088967 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.12.007 |